Bogart Wealth’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding RGNX
Bogart Wealth's RGNX Position: Q3 2026 in Review
Bogart Wealth sold out of Regenxbio (RGNX) in Q3 2026, closing a stake of 50 shares — an estimated $599 sold.
Bogart Wealth first reported a position in RGNX in Q2 2026 and held it in 1 quarter. The position peaked at $599 in Q2 2026. 174 funds tracked by Wall St. Rank hold RGNX as of Q3 2026.
- Bogart Wealth reported no remaining Regenxbio position as of Q3 2026 after selling out during the quarter.
- Bogart Wealth sold 50 Regenxbio shares in Q3 2026, an estimated $599.
- Bogart Wealth first reported a position in Regenxbio in Q2 2026 and held it in 1 quarter.
- Bogart Wealth's Regenxbio position peaked at $599 in Q2 2026.
- 174 funds tracked by Wall St. Rank held Regenxbio as of Q3 2026.
Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.